Gold tier: mechanically validated evidence, with its primary source.
1,754 evidence items · page 50 / 71
3.6 %At baseline, a prevalence of 3.6% HIV drug resistance was observed among 139 HIV-infected adult patients in Yaounde, Cameroon.
CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680
9 rangLe Cameroun est classé au neuvième rang parmi les pays les plus touchés par le paludisme.
CamerounpaludismeHAL · Unilimdocument of 67 observations
20,000 FFLe coût mensuel de la prise en charge thérapeutique par enfant malade de drépanocytose au Cameroun peut atteindre 20 000 FF en fonction du nombre de crises survenues dans le mois.
CameroundrépanocytoseHAL · Unilimdocument of 75 observations
36 casesAmong the 80 COVID-19 positive patients, fever was reported in 36 (45%).
CamerounCOVID-19published 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument of 12 observationsDOI 10.21203/rs.3.rs-78801/v1
8.2 %The risk of hemorrhagic stroke was 8.2%.
Camerounhemorrhagic strokeobserved 2016published 2018The New England journal of medicineeurope_pmcdocument of 12 observations
3.3 %The age-standardized prevalence of diabetes alone was 3.3% (95% CI: 1.5 to 5.1) among men in a semi-urban population in Bafoussam, Cameroon.
Cameroundiabète (non précisé)observed 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696
68.9 %The prevalence of multiclonal infections was 68.9% (421/611) in Mfou.
CamerounpaludismeHAL · Unilimdocument of 106 observations
5 %Coronary heart disease may affect 5–8% of type 2 diabetic patients.
Camerouncoronary heart disease · diabète de type 2published 2003Journal of cardiovascular riskeurope_pmcdocument of 10 observations
2.3 mmol/LRaised triglycerides were defined as >2.3 mmol/L in the study.
CamerounVIH/sidaobserved 2003–2014published 2018Global health, epidemiology and genomicseurope_pmcdocument of 2 observations
9.3 %Staphylococcus aureus accounted for 9.3% of isolated germs.
Camerounpied diabétique · Staphylococcus aureuspublished 2022The Pan African medical journaleurope_pmcdocument of 25 observations
44.7 %Le paludisme représente 44,7 % de la morbidité en zone de transition forêt-savane au Cameroun selon une enquête réalisée en 2004.
Camerounpaludismeobserved 2004HAL · Unilimdocument of 98 observations
20.3 %A 20.3% prevalence of G6PD deficiency was found in KPD patients without G6PD gene mutation.
Cameroundéficit en G6PD · ketosis-prone diabetespublished 2005The Journal of clinical endocrinology and metabolismeurope_pmcdocument of 3 observations
3,733 patientsA total of 3,733 patients were analyzed, including 2,036 (54.5%) who started ART at health centers and 1,697 (45.5%) at hospital level.
CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations
40.6 %Le paludisme représente 40,6 % de la morbidité en zone de forêt au Cameroun selon une enquête réalisée en 2004.
Camerounpaludismeobserved 2004HAL · Unilimdocument of 98 observations
6 %Chez les patients atteints de drépanocytose âgés de 7 mois à 35 ans au Cameroun, la prévalence d’accident vasculaire cérébral est de 6 à 7 %.
CamerounAVC · drépanocytoseHAL · Unilimdocument of 75 observations
81 %The prevalence of the 371V substitution in reverse transcriptase sequences was 81% among 57 HIV-1-infected treatment-naive individuals from Cameroon.
CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations
75,000,000 individualsIn 2016, 75 million girls worldwide were moderately or severely underweight.
Camerounmoderately or severely underweightobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 12 observations
66.3 %SARS-CoV-2 PCR was negative at day 10 in 63 out of 95 participants (66.3%) allocated to hydroxychloroquine-azithromycin.
CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838
From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions.
Camerounmalnutrition · obésité · severe obesityobserved 1985 to 2016published 2021eLifeeurope_pmcdocument of 3 observations
12 %The use of tests with low specificities could imply inclusion of up to 12% HIV negative people in ART programs.
CamerounVIH/sidapublished 2009PLoS ONEOpenAlexdocument of 3 observationsDOI 10.1371/journal.pone.0007702
958,800,000 casesThe second most prevalent neurological disorder in 2015 was migraine, with 958.8 million cases.
Camerounmigraineobserved 2015published 2017The Lancet. Neurologyeurope_pmcdocument of 10 observations
34.3 %Hypertension prevalence among men in Cameroon was 34.3% [95% CI 30.0–38.6].
Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165
13.6 %The prevalence of ischaemic heart disease among type 2 diabetes patients in Cameroon was 13.6%.
Cameroundiabète de type 2 · ischaemic heart diseasepublished 2012Cardiovascular journal of Africaeurope_pmcdocument of 11 observations
Glucagon suppression was decreased in response to oral and intravenous glucose in patients with ketosis-prone atypical diabetes.
Camerounketosis-prone atypical diabetespublished 2013Diabetes careeurope_pmcdocument of 3 observationsDOI 10.2337/dc12-0798
5 %The prevalence of the 11V substitution in protease sequences was 5% (3/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.
CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.